Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any retinitis pigmentosa in which the cause of the disease is a mutation in the TTC8 gene.
Features include always present findings: Bone spicule pigmentation of the retina, Reduced visual acuity, Rod-cone dystrophy, and Attenuation of retinal blood vessels. 15 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 3 | Macular degeneration, Visual impairment, Attenuation of retinal blood vessels |
TTC8 function has not been fully characterized.
Retinitis pigmentosa 51 is associated with mutations in the TTC8 gene on chromosome 14.
Genetic testing for TTC8 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for retinitis pigmentosa 51 has been reported in the published literature.
Phenotype severity distribution: 4 always present features.
No clinical trials have been registered for retinitis pigmentosa 51.
52 publications have been identified in PubMed for retinitis pigmentosa 51. Research spans Epidemiology / Natural History (37%), Basic Science / Preclinical (29%), and Case Report / Case Series (17%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 19 | 37% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 2:54 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Kidneys and urinary system
1 |
Abnormality of the kidney |
Bones and joints | 1 | Bone spicule pigmentation of the retina |
Brain and nerves | 1 | Global developmental delay |
Laboratory research
15 |
29% |
Patient case studies | 9 | 17% |
Testing and diagnosis research | 3 | 6% |
Research summaries | 3 | 6% |
Clinical study results | 2 | 4% |
New treatment approaches | 1 | 2% |
Kadyshev VV (2026). [PMID: 41847810](https://pubmed.ncbi.nlm.nih.gov/41847810/). *Vestn Oftalmol*. [Basic Science / Preclinical]
Seyedtaghia MR (2026). [PMID: 40252141](https://pubmed.ncbi.nlm.nih.gov/40252141/). *Biochem Genet*. [Basic Science / Preclinical]
Beaulieu C (2026). [PMID: 41954904](https://pubmed.ncbi.nlm.nih.gov/41954904/). *JAMA Ophthalmol*. [Basic Science / Preclinical]
Charng J (2026). [PMID: 41552664](https://pubmed.ncbi.nlm.nih.gov/41552664/). *Ophthalmol Sci*. [Epidemiology / Natural History]
Na H (2026). [PMID: 42256003](https://pubmed.ncbi.nlm.nih.gov/42256003/). *Ophthalmol Sci*. [Basic Science / Preclinical]
Marsh K (2026). [PMID: 41697461](https://pubmed.ncbi.nlm.nih.gov/41697461/). *Pharmacoecon Open*. [Epidemiology / Natural History]
Hühne T (2026). [PMID: 40903014](https://pubmed.ncbi.nlm.nih.gov/40903014/). *J Clin Endocrinol Metab*. [Epidemiology / Natural History]
Hisai T (2026). [PMID: 41140900](https://pubmed.ncbi.nlm.nih.gov/41140900/). *Ophthalmol Sci*. [Epidemiology / Natural History]
Parekh BJ (2026). [PMID: 41760091](https://pubmed.ncbi.nlm.nih.gov/41760091/). *Clin Exp Ophthalmol*. [Epidemiology / Natural History]
Dones AM (2026). [PMID: 41248229](https://pubmed.ncbi.nlm.nih.gov/41248229/). *Retina*. [Diagnostic / Biomarker]